Healthy Extracts Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Healthy Extracts Inc 's ROA in the second quarter of 2026?
Healthy Extracts Inc recorded a cumulative net loss of $-1 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -3.09%.

However, within the Consumer Non Cyclical sector 99 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2859, from total ROA ranking in the first quarter of 2026 at 3530.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	1206.68 %	1032.87 %	1070.11 %	961.31 %	0.44 %
Y / Y Net Income Change	-	-	-	-	-40.86 %
Net Income (TTM) in million	-1	-1	-1	-1	0
Return On Assets (TTM)	-3.09 %	-3.26 %	-5.98 %	-14.03 %	-17.42 %
GRCK's Total Ranking	# 2859	# 3530	# 3399	# 3516	# 3510
Total Assets (TTM) in million	33	27	28	26	2
Seq. Total Assets Change	19.36 %	-1.82 %	6.24 %	949.51 %	3.49 %
Seq. Net Income Change	-	-	-	-	-

GRCK's 5 Years Annual ROA >> Back to GRCK Management Effectiveness >> Compare GRCK ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 8
Sector	# 100
Overall	# 2827

Return On Assets Statistics
High	Average	Low
19.79 %	-377.13 %	-2981.54 %
(Dec 31 2019)		(Dec 31 2016)

Financial Statements
Healthy Extracts Inc 's Assets	$ 33 million	GRCK's Balance sheet
Healthy Extracts Inc 's Income	$ 0 million	Quarterly GRCK's Income Statement
GRCK's Income by Division		See GRCK's Income by Division

Annual Return On Assets	(Jun 30 2026) FY 2026	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022
Y / Y Total Assets Change	17.19 %	1070.11 %	-9.75 %	-5.25 %	10.9 %
Total Assets in million	33	28	2	3	3
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	0	-1	-1	-2	-1
Annual Return On Assets	-1.01 %	-3.17 %	-35.35 %	-93.85 %	-35.35 %

GRCK's 5 Years Annual ROA >> Back to GRCK Management Effectiveness >> Compare GRCK ROA to its Competitors

More Return On Assets Ratios
GRCK's' Return on Assets at Yahoo Finance
Legal Cannabis Industry Return On Assets Trends and Statistics
Consumer Non Cyclical Sector Roa Statistics
Roa Trends for overall market
GRCK's Roa Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GRCK's Competitors
Subscribers only: Roa for Healthy Extracts Inc 's Suppliers
Subscribers only: Return On Assets for GRCK's Customers

You may also want to know
GRCK's Roi	GRCK's Inventory Turnover Ratio	GRCK's Growth Rates	GRCK's Dividend Comparisons
	GRCK's Profitability Ratios	GRCK's Asset Turnover Ratio	GRCK's Dividend Growth
GRCK's Roe	GRCK's Valuation Ratios	GRCK's Financial Strength Ratios	GRCK's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Consumer Non Cyclical Sector

ROA

Date modified: 2026-08-17T17:16:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.